Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) rose 1.4% during trading on Wednesday . The company traded as high as $2.26 and last traded at $2.18. Approximately 30,929 shares changed hands during mid-day trading, a decline of 78% from the average daily volume of 142,233 shares. The stock had previously closed at $2.15.
Vivos Therapeutics Stock Performance
The stock has a fifty day moving average of $2.30 and a 200 day moving average of $5.01. The company has a market capitalization of $7.17 million, a PE ratio of -0.22 and a beta of 7.79.
Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) last posted its quarterly earnings results on Tuesday, May 14th. The company reported ($1.63) EPS for the quarter. Vivos Therapeutics had a negative return on equity of 1,879.30% and a negative net margin of 117.06%. The business had revenue of $3.42 million during the quarter.
Institutional Trading of Vivos Therapeutics
Vivos Therapeutics Company Profile
Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
Recommended Stories
- Five stocks we like better than Vivos Therapeutics
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Which Wall Street Analysts are the Most Accurate?
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Where Do I Find 52-Week Highs and Lows?
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Vivos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.